Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Weickert

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Endocrine Connections|November 19, 2017
Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumoursLogan Mills, Panagiotis Drymousis, Yogesh Vashist, et al.
Scientific Reports|January 12, 2022
Endoplasmic reticulum stress and the unfolded protein response in skeletal muscle of subjects suffering from peritoneal sepsisUta Barbara Metzing, Christian von Loeffelholz, Ricardo Steidl, et al.
European Journal of Endocrinology|August 25, 2022
Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patientsNina M T Meyer, Stefan Kabisch, Ulrike Dambeck, et al.
BMJ Open|May 6, 2016
Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional studySheharyar A Qureshi, Nicola Burch, Maralyn Druce, et al.
Journal of Neuroendocrinology|February 14, 2022
Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)John K Ramage, Elizabeth Friend, Jordan Randell, et al.
European Journal of Clinical Nutrition|September 22, 2006
Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose toleranceA L Garcia, B Otto, S-C Reich, et al.
Circulation|November 23, 2011
Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trialOzlem Gögebakan, Angela Kohl, Martin A Osterhoff, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 18, 2006
Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose toleranceA L Garcia, J Steiniger, S C Reich, et al.
Journal of Cell Communication and Signaling|November 13, 2017
Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesityChristopher Tacke, Krasimira Aleksandrova, Miriam Rehfeldt, et al.
The Journal of Clinical Endocrinology and Metabolism|November 23, 2006
Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36P T Pfluger, J Kampe, T R Castaneda, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Endocrine Connections|November 19, 2017
Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumoursLogan Mills, Panagiotis Drymousis, Yogesh Vashist, et al.
Scientific Reports|January 12, 2022
Endoplasmic reticulum stress and the unfolded protein response in skeletal muscle of subjects suffering from peritoneal sepsisUta Barbara Metzing, Christian von Loeffelholz, Ricardo Steidl, et al.
European Journal of Endocrinology|August 25, 2022
Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patientsNina M T Meyer, Stefan Kabisch, Ulrike Dambeck, et al.
BMJ Open|May 6, 2016
Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional studySheharyar A Qureshi, Nicola Burch, Maralyn Druce, et al.
Journal of Neuroendocrinology|February 14, 2022
Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)John K Ramage, Elizabeth Friend, Jordan Randell, et al.
European Journal of Clinical Nutrition|September 22, 2006
Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose toleranceA L Garcia, B Otto, S-C Reich, et al.
Circulation|November 23, 2011
Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trialOzlem Gögebakan, Angela Kohl, Martin A Osterhoff, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 18, 2006
Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose toleranceA L Garcia, J Steiniger, S C Reich, et al.
Journal of Cell Communication and Signaling|November 13, 2017
Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesityChristopher Tacke, Krasimira Aleksandrova, Miriam Rehfeldt, et al.
The Journal of Clinical Endocrinology and Metabolism|November 23, 2006
Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36P T Pfluger, J Kampe, T R Castaneda, et al.
Pageof 19